CF
USNA icon

Corebridge Financial’s Usana Health Sciences USNA Stock Holding History

Corebridge Financial’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,943
Closed -$160K – 2669
2025
Q1 		$160K Sell
5,943
-116
-2% -$3.67K ﹤0.01% 2203
2024
Q4 		$217K Sell
6,059
-471
-7% -$17.6K ﹤0.01% 2123
2024
Q3 		$248K Sell
6,530
-69
-1% -$2.83K ﹤0.01% 2106
2024
Q2 		$299K Buy
+6,599
New +$304K ﹤0.01% 1967

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Corebridge Financial's USNA Position: Q2 2025 in Review

Corebridge Financial sold out of Usana Health Sciences (USNA) in Q2 2025, closing a stake of 5,943 shares — an estimated $160K sold.

Corebridge Financial first reported a position in USNA in Q2 2024 and held it in 4 quarters. The position peaked at $299K in Q2 2024. 164 funds tracked by Wall St. Rank hold USNA as of Q2 2025.

  • Corebridge Financial reported no remaining Usana Health Sciences position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 5,943 Usana Health Sciences shares in Q2 2025, an estimated $160K.
  • Corebridge Financial first reported a position in Usana Health Sciences in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Usana Health Sciences position peaked at $299K in Q2 2024.
  • 164 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.